Clinical Trial Update: A Study Comparing Subcutaneous Rapid Acting Insulin and One Formulation of Inhaled Insulin in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing subcutaneous rapid-acting insulin with a formulation of inhaled insulin in adults with Type 2 diabetes completed, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Inhaled insulin formulation (Technosphere insulin)
• Subcutaneous rapid-acting insulin

Snippet

Sponsor: Mannkind Corporation | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-10-16